small molecule glp-1 agonist In patients with #obesity, incretin-based therapies such as receptor agonists are reported to result in mean weight reductions of approximately 15 to 20% along with additional health benefits, including decreased cardiovascular Small Molecule GLP-1 Agonists vs
Description
10.1002/oby.23673
Additionally, we provide guidance on lifestyle modifications, such as a healthy diet and exercise, to enhance results
Some studies have suggested that the proliferation and apoptosis of granulosa cells (GCs) are the root causes of follicular development and atresia, with forkhead box protein O1 (FoxO1) playing an important role in promoting PCOS follicular atresia and GCs apoptosis (162, 163)
35,36 Although some studies report smaller reductions in muscle mass, many scientists argue that these findings should not be ignored due to the high metabolic rate of skeletal muscle which plays an important role in maintaining significant weight loss
[DOI] [PMC free article] [PubMed] [Google Scholar] 947.Irwin N., Pathak V., Flatt P.R
